Insider Buying: Cardlytics (NASDAQ:CDLX) CFO Buys 50,000 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO David Thomas Evans acquired 50,000 shares of the firm’s stock in a transaction that occurred on Monday, May 18th. The stock was bought at an average price of $0.63 per share, for a total transaction of $31,500.00. Following the completion of the transaction, the chief financial officer owned 317,930 shares of the company’s stock, valued at $200,295.90. The trade was a 18.66% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

David Thomas Evans also recently made the following trade(s):

• On Friday, May 15th, David Thomas Evans acquired 150,000 shares of Cardlytics stock. The stock was bought at an average price of $0.65 per share, for a total transaction of $97,500.00.

Cardlytics Stock Down 1.6%

Shares of CDLX stock traded down $0.01 during trading on Tuesday, hitting $0.60. The company had a trading volume of 869,236 shares, compared to its average volume of 1,103,752. The stock’s 50-day moving average is $0.87 and its two-hundred day moving average is $1.06. The stock has a market capitalization of $34.34 million, a price-to-earnings ratio of -0.34 and a beta of 0.67. Cardlytics, Inc. has a 52 week low of $0.57 and a 52 week high of $3.28.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings data on Wednesday, March 4th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.08). Cardlytics had a negative return on equity of 956.56% and a negative net margin of 46.03%.The company had revenue of $56.10 million during the quarter, compared to the consensus estimate of $54.46 million. On average, research analysts predict that Cardlytics, Inc. will post -0.11 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of CDLX. Bank of America Corp DE grew its stake in shares of Cardlytics by 262.7% during the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after buying an additional 1,182,593 shares during the last quarter. Quinn Opportunity Partners LLC lifted its position in Cardlytics by 900.0% in the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock valued at $2,673,000 after purchasing an additional 990,000 shares during the last quarter. UBS Group AG lifted its position in Cardlytics by 112.5% in the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock valued at $1,113,000 after purchasing an additional 242,536 shares during the last quarter. Raymond James Financial Inc. lifted its position in Cardlytics by 36,915.3% in the third quarter. Raymond James Financial Inc. now owns 133,255 shares of the company’s stock valued at $324,000 after purchasing an additional 132,895 shares during the last quarter. Finally, Jane Street Group LLC lifted its position in Cardlytics by 263.0% in the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after purchasing an additional 117,687 shares during the last quarter. 68.10% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CDLX shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a report on Friday, April 10th. Wall Street Zen upgraded Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, April 4th. Lake Street Capital set a $1.00 price objective on Cardlytics in a research report on Friday, May 8th. Bank of America reiterated an “underperform” rating on shares of Cardlytics in a research report on Thursday, March 5th. Finally, Evercore set a $1.00 price objective on Cardlytics in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell” and an average price target of $1.00.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.